These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4218695)

  • 41. Von Willebrand disease "stimulating factor" in porcine plasma.
    Chan JY; Owen CA; Bowie EJ; Didisheim P; Thompson JH; Muhrer ME; Zollman PE
    Am J Physiol; 1968 May; 214(5):1219-24. PubMed ID: 5300695
    [No Abstract]   [Full Text] [Related]  

  • 42. [Immunological studies on factor VIII in hemophilia and von Willebrand disease].
    Casillas G; Simonetti C; Pavlovsky A
    Medicina (B Aires); 1977; 37(3):215-22. PubMed ID: 302385
    [No Abstract]   [Full Text] [Related]  

  • 43. [Efficiency and limits of immunologic methods in the diagnosis of blood coagulation].
    Schwick HG; Trobisch H; Heimburger N
    Internist (Berl); 1973 Apr; 14(4):160-9. PubMed ID: 4197663
    [No Abstract]   [Full Text] [Related]  

  • 44. Absence of correlation between X chromosome inactivation pattern and plasma concentration of factor VIII and factor IX in carriers of haemophilia A and B.
    Orstavik KH; Scheibel E; Ingerslev J; Schwartz M
    Thromb Haemost; 2000 Mar; 83(3):433-7. PubMed ID: 10744150
    [TBL] [Abstract][Full Text] [Related]  

  • 45. From the Centers for Disease Control and Prevention. Hepatitis A among persons with hemophilia who received clotting factor concentrate--United States, September-December 1995.
    JAMA; 1996 Feb; 275(6):427-8. PubMed ID: 8627951
    [No Abstract]   [Full Text] [Related]  

  • 46. Desmopressin: a nontransfusional treatment of hemophilia and von Willebrand disease.
    Mannucci PM; Cattaneo M
    Haemostasis; 1992; 22(5):276-80. PubMed ID: 1478539
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Hemophilia. New aspects in diagnosis and treatment].
    Gormsen J
    Ugeskr Laeger; 1973 Nov; 135(46):2487-93. PubMed ID: 4592776
    [No Abstract]   [Full Text] [Related]  

  • 48. [Efficacy in viral inactivation of the concentrates of factor VIII and IX by the solvent/detergent procedure. Evaluation in patients with hemophilia].
    Guerois C; Parquet A; Vicariot M; Lecoeur FF; Maisonneuve P; Courouce AM; Dubois F; Laurian Y
    Presse Med; 1991 Jun; 20(25):1163-6. PubMed ID: 1830653
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Test for detection of hemophilia].
    Poppa C; Enache F; Cernat M
    Stud Cercet Med Interna; 1970; 11(6):521-31. PubMed ID: 5313814
    [No Abstract]   [Full Text] [Related]  

  • 50. A new treatment for von Willebrand's syndrome.
    Ozsoylu S; Corbacioğlu B
    Turk J Pediatr; 1967 Jan; 9(1):1-7. PubMed ID: 5299222
    [No Abstract]   [Full Text] [Related]  

  • 51. von Willebrand disease masquerading as haemophilia A.
    Mazurier C
    Thromb Haemost; 1992 Apr; 67(4):391-6. PubMed ID: 1631785
    [No Abstract]   [Full Text] [Related]  

  • 52. [Revision consensus hemophilia: treatment and responsibility. Nederlandse Vereniging van Hemophilia Patients].
    Briët E; Mauser-Bunschoten EP
    Ned Tijdschr Geneeskd; 1997 Dec; 141(52):2566-71. PubMed ID: 9555158
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hemophilia prophylaxis.
    JAMA; 1970 Jun; 212(13):2256-7. PubMed ID: 5310463
    [No Abstract]   [Full Text] [Related]  

  • 54. An inhibitor to factor VIII:C in a patient with possible combined haemophilia A and von Willebrand's disease.
    Taylor LD; Dean FL; Tiedemann K; Ekert H
    Thromb Haemost; 1986 Apr; 55(2):158-61. PubMed ID: 3087000
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Determination of prothromboplastin factors (Factors VIII, IX, XI and XII)].
    Kagami M
    Nihon Rinsho; 1976; 34 suppl():2407-24. PubMed ID: 792517
    [No Abstract]   [Full Text] [Related]  

  • 56. Cold storage of citrated whole blood induces drastic time-dependent losses in factor VIII and von Willebrand factor: potential for misdiagnosis of haemophilia and von Willebrand disease.
    Böhm M; Täschner S; Kretzschmar E; Gerlach R; Favaloro EJ; Scharrer I
    Blood Coagul Fibrinolysis; 2006 Jan; 17(1):39-45. PubMed ID: 16607078
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Concentrated preparations of Factor 8 (antihaemophilic globulin) in the management of haemophilia A and von Willebrand's disease.
    Castaldi PA; Somer JB; Schiff P; Blackburn CR
    Med J Aust; 1967 Sep; 2(11):481-5. PubMed ID: 5299300
    [No Abstract]   [Full Text] [Related]  

  • 58. No inhibitor development after continuous infusion of factor concentrates in subjects with bleeding disorders undergoing surgery: a prospective study.
    Auerswald G; Bade A; Haubold K; Overberg D; Masurat S; Moorthi C
    Haemophilia; 2013 May; 19(3):438-44. PubMed ID: 23279056
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Factor VIII-like antigen in haemophilia A and in Willebrand's disease (author's transl)].
    Blatný J; Procházka J; Bártová A; Fischerová E; Slepicka L; Skodová M
    Cas Lek Cesk; 1975 Sep; 114(38):1174-6. PubMed ID: 1081010
    [No Abstract]   [Full Text] [Related]  

  • 60. [Laboratory diagnosis of hemophilias].
    Egli H
    Dtsch Med J; 1968 Jul; 19(14):495-9. PubMed ID: 5305712
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.